CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

ConferenceIHEEZOBYOOVIZPositive
AI Analysis

Summary

Harrow is presenting clinical evidence supporting its IHEEZO and BYOOVIZ drugs at the ASRS 2026 Annual Meeting. The announcement highlights growing clinical data for these products.

Importance:3/10
Sentiment:
0.40
conference presentationclinical evidenceASRS 2026
Related Companies

Read the original article

Published by yahoo_finance on July 20, 2026 11:00 AM

Read Original